Literature DB >> 23643670

Acidic tumor microenvironment downregulates hMLH1 but does not diminish 5-fluorouracil chemosensitivity.

Moriya Iwaizumi1, Stephanie Tseng-Rogenski, John M Carethers.   

Abstract

Human DNA mismatch repair (MMR) recognizes and binds 5-fluorouracil (5FU) incorporated into DNA and triggers a MMR-dependent cell death. Absence of MMR in a patient's colorectal tumor abrogates 5FU's beneficial effects on survival. Changes in the tumor microenvironment like low extracellular pH (pHe) may diminish DNA repair, increasing genomic instability. Here, we explored if low pHe modifies MMR recognition of 5FU, as 5FU can exist in ionized and non-ionized forms depending on pH. We demonstrate that MMR-proficient cells at low pHe show downregulation of hMLH1, whereas expression of TDG and MBD4, known DNA glycosylases for base excision repair (BER) that can remove 5FU from DNA, were unchanged. We show in vitro that 5FU within DNA pairs with adenine (A) at high and low pH (in absence of MMR and BER). Surprisingly, 5FdU:G was repaired to C:G in hMLH1-deficient cells cultured at both low and normal pHe, similar to MMR-proficient cells. Moreover, both hMSH6 and hMSH3, components of hMutSα and hMutSβ, respectively, bound 5FU within DNA (hMSH6>hMSH3) but is influenced by hMLH1. We conclude that an acidic tumor microenvironment triggers downregulation of hMLH1, potentially removing the execution component of MMR for 5FU cytotoxicity, whereas other mechanisms remain stable to implement overall 5FU sensitivity.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23643670      PMCID: PMC3770844          DOI: 10.1016/j.mrfmmm.2013.04.006

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  58 in total

1.  Biphasic kinetics of the human DNA repair protein MED1 (MBD4), a mismatch-specific DNA N-glycosylase.

Authors:  F Petronzelli; A Riccio; G D Markham; S H Seeholzer; J Stoerker; M Genuardi; A T Yeung; Y Matsumoto; A Bellacosa
Journal:  J Biol Chem       Date:  2000-10-20       Impact factor: 5.157

2.  HNPCC-like cancer predisposition in mice through simultaneous loss of Msh3 and Msh6 mismatch-repair protein functions.

Authors:  N de Wind; M Dekker; N Claij; L Jansen; Y van Klink; M Radman; G Riggins; M van der Valk; K van't Wout; H te Riele
Journal:  Nat Genet       Date:  1999-11       Impact factor: 38.330

3.  The distinct spectra of tumor-associated Apc mutations in mismatch repair-deficient Apc1638N mice define the roles of MSH3 and MSH6 in DNA repair and intestinal tumorigenesis.

Authors:  M Kuraguchi; K Yang; E Wong; E Avdievich; K Fan; R D Kolodner; M Lipkin; A M Brown; R Kucherlapati; W Edelmann
Journal:  Cancer Res       Date:  2001-11-01       Impact factor: 12.701

4.  Diminished DNA repair and elevated mutagenesis in mammalian cells exposed to hypoxia and low pH.

Authors:  J Yuan; L Narayanan; S Rockwell; P M Glazer
Journal:  Cancer Res       Date:  2000-08-15       Impact factor: 12.701

5.  The versatile thymine DNA-glycosylase: a comparative characterization of the human, Drosophila and fission yeast orthologs.

Authors:  Ulrike Hardeland; Marc Bentele; Josef Jiricny; Primo Schär
Journal:  Nucleic Acids Res       Date:  2003-05-01       Impact factor: 16.971

6.  Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.

Authors:  Christine M Ribic; Daniel J Sargent; Malcolm J Moore; Stephen N Thibodeau; Amy J French; Richard M Goldberg; Stanley R Hamilton; Pierre Laurent-Puig; Robert Gryfe; Lois E Shepherd; Dongsheng Tu; Mark Redston; Steven Gallinger
Journal:  N Engl J Med       Date:  2003-07-17       Impact factor: 91.245

7.  MBD4 deficiency reduces the apoptotic response to DNA-damaging agents in the murine small intestine.

Authors:  Owen James Sansom; Joanna Zabkiewicz; Stefan Mark Bishop; Jackie Guy; Adrian Bird; Alan Richard Clarke
Journal:  Oncogene       Date:  2003-10-16       Impact factor: 9.867

8.  Decreased expression of the DNA mismatch repair gene Mlh1 under hypoxic stress in mammalian cells.

Authors:  Valia T Mihaylova; Ranjit S Bindra; Jianling Yuan; Denise Campisi; Latha Narayanan; Ryan Jensen; Frank Giordano; Randall S Johnson; Sara Rockwell; Peter M Glazer
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

Review 9.  MRI of the tumor microenvironment.

Authors:  Robert J Gillies; Natarajan Raghunand; Gregory S Karczmar; Zaver M Bhujwalla
Journal:  J Magn Reson Imaging       Date:  2002-10       Impact factor: 4.813

10.  Both hMutSα and hMutSß DNA mismatch repair complexes participate in 5-fluorouracil cytotoxicity.

Authors:  Akihiro Tajima; Moriya Iwaizumi; Stephanie Tseng-Rogenski; Betty L Cabrera; John M Carethers
Journal:  PLoS One       Date:  2011-12-02       Impact factor: 3.240

View more
  5 in total

Review 1.  Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.

Authors:  John M Carethers; Elena M Stoffel
Journal:  World J Gastroenterol       Date:  2015-08-21       Impact factor: 5.742

Review 2.  EMAST is a Form of Microsatellite Instability That is Initiated by Inflammation and Modulates Colorectal Cancer Progression.

Authors:  John M Carethers; Minoru Koi; Stephanie S Tseng-Rogenski
Journal:  Genes (Basel)       Date:  2015-03-31       Impact factor: 4.096

3.  Production of truncated MBD4 protein by frameshift mutation in DNA mismatch repair-deficient cells enhances 5-fluorouracil sensitivity that is independent of hMLH1 status.

Authors:  Satoshi Suzuki; Moriya Iwaizumi; Stephanie Tseng-Rogenski; Yasushi Hamaya; Hiroaki Miyajima; Shigeru Kanaoka; Ken Sugimoto; John M Carethers
Journal:  Cancer Biol Ther       Date:  2016-04-26       Impact factor: 4.742

4.  Explosive mutation accumulation triggered by heterozygous human Pol ε proofreading-deficiency is driven by suppression of mismatch repair.

Authors:  Karl P Hodel; Richard de Borja; Erin E Henninger; Brittany B Campbell; Nathan Ungerleider; Nicholas Light; Tong Wu; Kimberly G LeCompte; A Yasemin Goksenin; Bruce A Bunnell; Uri Tabori; Adam Shlien; Zachary F Pursell
Journal:  Elife       Date:  2018-02-28       Impact factor: 8.140

5.  Trispecific natural killer cell nanoengagers for targeted chemoimmunotherapy.

Authors:  Kin Man Au; Steven I Park; Andrew Z Wang
Journal:  Sci Adv       Date:  2020-07-03       Impact factor: 14.136

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.